Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Novo Nordisk A/S
(NYSE:NVO)
100.39
Delayed Data
As of Dec 01
-1.45
/
-1.42%
Today’s Change
62.41
Today
|||
52-Week Range
105.69
+48.35%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest NVO News
|
Press Releases
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?
5:53am / MotleyFool.com - Paid Partner Content
Could Ozempic Harm These 3 Medical Device Stocks?
Nov 25 / MotleyFool.com - Paid Partner Content
Market Today: Coinbase Surges Amid Bitcoin Rally, Gold Hits Record High
Dec 01 / GuruFocus News - Paid Partner Content
Here's Why Investors Should Hold Encompass Health (EHC) Now
Nov 24 / Zacks.com - Paid Partner Content
Will Novo Nordisk Be a Trillion-Dollar Stock by 2030?
Dec 01 / MotleyFool.com - Paid Partner Content
Top Stock Reports for Eli Lilly, Accenture & The TJX Companies
Nov 24 / Zacks.com - Paid Partner Content
FDA Accepts Karuna's (KRTX) NDA Filing for Schizophrenia Drug
Nov 30 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) to Expand Manufacturing Site in France
Nov 24 / Zacks.com - Paid Partner Content
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
Nov 30 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVO & LLY to Expand Manufacturing Capacity in Europe, & More
Nov 24 / Zacks.com - Paid Partner Content
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
Nov 30 / MotleyFool.com - Paid Partner Content
New Strong Buy Stocks for November 24th
Nov 24 / Zacks.com - Paid Partner Content
Vanguard Health Care Fund's Strategic Moves: Spotlight on Ono Pharmaceutical Co Ltd
Nov 29 / GuruFocus News - Paid Partner Content
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
Nov 23 / MotleyFool.com - Paid Partner Content
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
Nov 29 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Stock Outperforms Industry YTD: Here's Why
Nov 23 / Zacks.com - Paid Partner Content
Is Alpine Immune Sciences (ALPN) Outperforming Other Medical Stocks This Year?
Nov 29 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Novo Nordisk Bank of America, Netflix, Johnson & Johnson and TotalEnergies
Nov 22 / Zacks.com - Paid Partner Content
Merck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study
Nov 29 / Zacks.com - Paid Partner Content
Merck (MRK) to Acquire Private Neuroscience Company for $610M
Nov 22 / Zacks.com - Paid Partner Content
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
Nov 29 / MotleyFool.com - Paid Partner Content
Here's How Much You'd Have If You Invested $1000 in Novo Nordisk a Decade Ago
Nov 22 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag
Nov 28 / Zacks.com - Paid Partner Content
Top Analyst Reports for Novo Nordisk, Bank of America & Netflix
Nov 21 / Zacks.com - Paid Partner Content
3 Large Drug Stocks That Have Outperformed Industry YTD
Nov 28 / Zacks.com - Paid Partner Content
J&J (JNJ) Seeks Expanded Use of Lung Cancer Drug Rybrevant
Nov 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Gartner, The Progressive, InterContinental Hotels, Cboe Global Markets and Novo Nordisk
Nov 28 / Zacks.com - Paid Partner Content
Is Novo Nordisk (NVO) a Buy as Wall Street Analysts Look Optimistic?
Nov 21 / Zacks.com - Paid Partner Content
5 Must-Buy Stocks at 52-Week High With More Upside for 2024
Nov 27 / Zacks.com - Paid Partner Content
Lilly (LLY) to Build $2.5B Plant to Meet Increased Drug Demand
Nov 20 / Zacks.com - Paid Partner Content
Beat the Market Like Zacks: UnitedHealth, Casey's, Cencora in Focus
Nov 27 / Zacks.com - Paid Partner Content
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
Nov 20 / MotleyFool.com - Paid Partner Content
4 Must-Buy Profitable Stocks Using Net Income Ratio
Nov 27 / Zacks.com - Paid Partner Content
3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist
Nov 20 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce
Nov 27 / Zacks.com - Paid Partner Content
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
Nov 19 / MotleyFool.com - Paid Partner Content
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
Nov 26 / MotleyFool.com - Paid Partner Content